|
Adenoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma.
|
16327996 |
2006 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
In human bladder cancer, overexpression of S100A4, S100A8 or S100A11 are associated with stage progression, invasion, metastasis and poor survival.
|
17523080 |
2007 |
|
Lung Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis.
|
17537172 |
2007 |
|
Degenerative polyarthritis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Chondrocyte RAGE expression and S100A11 release are stimulated by IL-1beta in vitro and increase in OA cartilage in situ.
|
18523305 |
2008 |
|
Degenerative polyarthritis
|
0.030 |
Biomarker
|
disease |
LHGDN |
Chondrocyte RAGE expression and S100A11 release are stimulated by IL-1beta in vitro and increase in OA cartilage in situ.
|
18523305 |
2008 |
|
Liver carcinoma
|
0.030 |
AlteredExpression
|
disease |
LHGDN |
S100A6 and S100A11 can discriminate significantly between the two primary tumor entities, CRC and HCC, whereas S100A6 allows the discrimination of metastases and HCC.
|
19048101 |
2008 |
|
Dermatitis, Atopic
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.
|
18385759 |
2008 |
|
Colorectal Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
We expanded our study in 89 clinical colorectal tumor samples to validate this finding and correlates S100A11 expression in human colorectal cancer tissues with various stages of the tumor by Western blotting and immunohistochemical staining.
|
18340452 |
2008 |
|
Dermatitis, Atopic
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We have demonstrated that expression of S100A11, a calcium-binding protein involved in keratinocyte differentiation, is downregulated in AD.
|
19577285 |
2009 |
|
Eczema
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have demonstrated that expression of S100A11, a calcium-binding protein involved in keratinocyte differentiation, is downregulated in AD.
|
19577285 |
2009 |
|
Influenza
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, deficient S100A11 gene expression significantly impaired IL-29 (IFN-lambda1) responsiveness (2' 5'-oligoadenylate synthetase and Myxovirus [influenza virus] resistance induction) and its anti-VV effects in keratinocytes.
|
19577285 |
2009 |
|
Pterygium
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, a distinct alteration of localization of S100A11 expression was observed in pterygium epithelium compared to the conjunctiva.
|
19223989 |
2009 |
|
Pterygium Of Conjunctiva And Cornea
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, a distinct alteration of localization of S100A11 expression was observed in pterygium epithelium compared to the conjunctiva.
|
19223989 |
2009 |
|
Pterygium of eye
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, a distinct alteration of localization of S100A11 expression was observed in pterygium epithelium compared to the conjunctiva.
|
19223989 |
2009 |
|
Neoplasm Invasiveness
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
|
20388789 |
2010 |
|
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Four of these (AHNAK, septin-9, eIF4E, and S100A11) are shown to be essential for pseudopod protrusion and tumor cell migration and invasion.
|
20388789 |
2010 |
|
Tumor Cell Invasion
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Four of these (AHNAK, septin-9, eIF4E, and S100A11) are shown to be essential for pseudopod protrusion and tumor cell migration and invasion.
|
20388789 |
2010 |
|
Adenocarcinoma
|
0.040 |
Biomarker
|
group |
BEFREE |
Further immunohistochemistry staining was positive for S100A11 only in non-small cell lung cancer (NSCLC) (ADC, SCC, large cell carcinomas, et al.), but not SCLC.
|
21861103 |
2012 |
|
Non-Small Cell Lung Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Further immunohistochemistry staining was positive for S100A11 only in non-small cell lung cancer (NSCLC) (ADC, SCC, large cell carcinomas, et al.), but not SCLC.
|
21861103 |
2012 |
|
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further immunohistochemistry staining was positive for S100A11 only in non-small cell lung cancer (NSCLC) (ADC, SCC, large cell carcinomas, et al.), but not SCLC.
|
21861103 |
2012 |
|
Choriocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The effects of S100A11 on embryo implantation were examined using in vivo mouse model, and JAr (a human choriocarcinoma cell line) spheroid attachment assays.
|
22869607 |
2012 |
|
Bacterial Endocarditis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using transcriptional signatures of blood samples, we identified S100A11 as a potential diagnostic marker of IE, and AQP9 as a potential prognostic factor.
|
22319637 |
2012 |
|
leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of four genes was up-regulated: Gardner-Rasheed feline sarcoma viral oncogene homolog, v-Fgr (FGR), S100 calcium binding protein A11 (S100A11), formyl peptide receptor 1 (FPR1), ArfGAP with RhoGAP domain, ankyrin repeat and PH1 domain (ARAP1), while the expression of growth hormone 1 (GH1) was found to be down-regulated in resistant leukemia blasts.
|
22287738 |
2012 |
|
Carcinoma, Large Cell
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further immunohistochemistry staining was positive for S100A11 only in non-small cell lung cancer (NSCLC) (ADC, SCC, large cell carcinomas, et al.), but not SCLC.
|
21861103 |
2012 |
|
Malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The specific expression and subcellular distribution of S100A11 were examined in 78 paraffin-embedded lung cancers, 2 benign lung diseases as well as 22 healthy lung tissues by immunohistochemistry.
|
21861103 |
2012 |